Piotr Borowicz

Title: The Innovations of Piotr Borowicz

Introduction

Piotr Borowicz is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and vaccine antigens. With a total of four patents to his name, Borowicz's work has broad implications for immunoprophylaxis and immunotherapy.

Latest Patents

Among his latest patents, Borowicz has developed monoclonal antibodies against hemagglutinin of H5-serotype influenza viruses. These antibodies are selected from a specific group and have applications in both humans and animals. His invention also includes hybridomas that produce these antibodies, along with compositions and diagnostic kits for detecting H5-serotype influenza viruses. Another significant patent involves an influenza virus hemagglutinin protein as a vaccine antigen, particularly a fragment of H5 hemagglutinin from the highly pathogenic avian influenza virus H5N1 strain. This protein is intended for use in vaccines administered to chickens, enhancing their immunity against HPAIV H5N1.

Career Highlights

Borowicz has worked with prominent institutions such as the Institute of Biotechnology and Antibiotics and the Łukasiewicz Research Network—Institute of Biotechnology and Antibiotics. His career reflects a strong commitment to advancing biotechnological research and applications.

Collaborations

Throughout his career, Borowicz has collaborated with notable colleagues, including Violetta Cecuda-Adamczewska and Violetta Sączyńska. These partnerships have contributed to the success of his research and innovations.

Conclusion

Piotr Borowicz's contributions to biotechnology, particularly in the development of monoclonal antibodies and vaccine antigens, highlight his role as an influential inventor in the field. His work continues to impact immunology and public health.